Skip to content

AstraZeneca withdraws its Covid-19 vaccine from sale due to falling demand

The British pharmaceutical giant AstraZeneca announced on Wednesday that it is withdrawing its coronavirus vaccine from sale COVID-19 Vaxzevria, one of the first to hit the market during the pandemic, due to the drop in demand.

“Taking into account that multiple vaccines have been developed against COVID-19there is an excess of updated vaccines” in the face of different variants of the virus, “which translates into a drop in demand for Vaxzevriawhich is no longer manufactured or distributed”, explained the group in a statement.

LOOK: Mexico: experts say the government could have saved 224,000 people if it had better managed the COVID-19 pandemic

“By him “AstraZeneca has decided to initiate the withdrawal of marketing authorization for Vaxzevria in Europe.”he added.

The European Medicines Agency (EMA) indicated on Tuesday on its website that The sales authorization for Vaxzevria was withdrawn “at the request of the holder of the marketing authorization”, that is, the pharmaceutical laboratory.

The group will also “work with other regulators around the world to begin withdrawing authorizations […] where there are no anticipated future demands for the vaccine.”

Astrazeneca claims to want to “close this chapter”. “We are very proud of the role that Vaxzevria it was necessary to end the pandemic”, added the text.

“According to independent estimates, “More than 6.5 million lives were saved in just the first year of use” of the medicine.“and more than 3,000 million doses have been distributed around the world”, he explained.

it is vaccineone of the first to hit the market, even if these serums were not the specialty of Astrazenecahad several setbacks, including the lack of marketing authorization in the United States.

There were also supply problems in Europeamid fears of the risk of thrombosis which could result after the death of several people.

Source: Elcomercio

Share this article:
globalhappenings news.jpg
most popular